Ayantunde A A, Parsons S L
Department of Surgery, Nottingham University Hospitals, Nottingham City Hospital Campus, Nottingham, UK.
Ann Oncol. 2007 May;18(5):945-9. doi: 10.1093/annonc/mdl499. Epub 2007 Feb 13.
Malignant ascites is a manifestation of end stage events in a variety of cancers and associated with a poor prognosis. We evaluated the pattern of cancers causing malignant ascites and factors affecting survival.
Patients coded with the International Classification of Diseases-9 coding system for malignant ascites over a 2-year period were reviewed. The clinicopathological data and patients' survival were compared among cancer groups.
There were 209 patients (140 females and 69 males), median age being 67 (30-98) years. The commonest cancer was ovarian followed by gastrointestinal (GI) cancers. Fifty-eight per cent of the patients had symptoms related to the ascites. Liver metastases were significantly commoner in the GI cancers (P = 0.0001). Fifty-four per cent of our patients presented with ascites at the initial diagnosis of their cancer. Paracentesis was given to 112, diuretics to 70 and chemotherapy to 103 patients. The median survival following diagnosis of ascites was 5.7 months. Ovarian cancer favoured longer survival while low serum albumin, low serum protein and liver metastases adversely affected survival. The independent prognostic factors for survival were cancer type, liver metastases and serum albumin.
The identified independent prognostic factors should be used to select patients for multimodality therapy for adequate palliation.
恶性腹水是多种癌症终末期事件的一种表现,与预后不良相关。我们评估了导致恶性腹水的癌症类型及影响生存的因素。
回顾了在两年期间使用国际疾病分类第九版编码系统编码为恶性腹水的患者。对各癌症组的临床病理数据及患者生存情况进行了比较。
共有209例患者(140例女性,69例男性),中位年龄为67岁(30 - 98岁)。最常见的癌症是卵巢癌,其次是胃肠道(GI)癌。58%的患者有与腹水相关的症状。GI癌患者的肝转移明显更常见(P = 0.0001)。我们54%的患者在癌症初诊时即出现腹水。112例患者接受了腹腔穿刺术,70例使用了利尿剂,103例接受了化疗。腹水诊断后的中位生存期为5.7个月。卵巢癌患者生存期较长,而低血清白蛋白、低血清蛋白和肝转移对生存有不利影响。生存的独立预后因素为癌症类型、肝转移和血清白蛋白。
所确定的独立预后因素应用于选择患者进行多模式治疗以实现充分的姑息治疗。